TB-500
10 mg
€ 42,00
per vialComing soonTB-500 — 10 mg per research vial. Exact supplier identity and technical documentation remain subject to verification. For laboratory research only; not for human or veterinary use.
- Reference
- MVP / 010
- Strength
- 10 mg
- Availability
- Coming soon
- Handling
- Store cool and dry, away from light. Laboratory handling only.
- Shipping
- PostNL within the Netherlands, € 4,99 per order
Specification
For research only. Not for human use.
Key research areas
- Thymosin beta-4 fragment biology
- Actin-binding and cytoskeletal organisation
- Cell migration and motility assays
- Angiogenesis-related signalling
- Sequence-verification and identity research
Potential benefits observed in research
- Parent-peptide research links the actin-binding region to enhanced cell migration.
- Associated in animal models with new blood-vessel formation in injured tissue.
- Studied for reduced scarring and improved flexibility markers in tissue models.
- Reported anti-inflammatory activity in preclinical settings.
Reported observations from published studies under controlled conditions. They do not establish the safety, quality or performance of this research material.
Research documentation
TB-500 — 10 mg
TB-500 is commonly used as a name for a synthetic seven-amino-acid fragment of thymosin beta-4, although inconsistent commercial naming makes exact molecular identification essential. The fragment includes a sequence associated with the parent peptide's actin-binding region. Actin is a structural protein involved in cell shape and movement, making this region of interest in research on cytoskeletal organisation and cell migration.
Key Research Areas
- Peptide-fragment biology
- actin-related mechanisms
- cytoskeletal organisation
- cell migration
Proposed mechanisms for the fragment remain incompletely established, and results obtained with full-length thymosin beta-4 or differently modified fragments cannot automatically be assigned to TB-500. The FDA's scientific review identified major gaps in human evidence. MVP TB-500 is a research material, with no established therapeutic benefit claimed for the supplied product. FDA scientific review.
For research purposes only. Not for human consumption or therapeutic use.
